SlideShare a Scribd company logo
Treatment of cardiac Arrhythmias
For Reform Students
By M. H. Farjoo M.D , Ph.D
Shahid Beheshti University of Medical Sciences
Treatment of Cardiac Arrhythmias
 Drug Classes
 Supraventricular Arrhythmias
 Atrial Flutter
 Atrial Fibrillation
 AV Nodal Reentrant Tachycardia
 Preexcitation Syndrome (WPW)
 AV Block
 PVC
 Ventricular Tachycardia
 Ventricular Flutter & Fibrillation & arrest
Drug Classes
Supraventricular Arrhythmias
 Atrial fibrillation and atrial flutter are common
supraventricular tachycardias.
 Premature atrial complexes (PAC), sinus arrhythmia,
sinus tachycardia, and sinus bradycardia usually do
NOT require drug therapy.
 In symptomatic patients with PAC, treatment with a
beta blocker or a CCB can be attempted.
Atrial Flutter
 Cardioversion (synchronous, 50 J) is the treatment of
choice.
 Catheter ablation is preferred for stable patients who
do not require immediate cardioversion.
 Procainamide or amiodarone can be given.
Amiodarone 150 mg / 3 ml
Price of each ampule: 3,500 Toman
Atrial Fibrillation (AF or AFib)
 AF is the most prevalent arrhythmia and 33% of
arrhythmia-related hospitalizations are for AF.
 AF treatment is based upon:
 Rate control or rhythm control
 Prevention of Thromboembolism
 Pharmacologic rhythm-control and rate-control
strategies result in similar outcomes.
Atrial Fibrillation (AF or AFib)
 In the absence of preexcitation, a beta blocker or
nondihydropyridine CCB is used for AF.
 IV digoxin or amiodarone is used in AF with heart
failure and without accessory pathway.
 Digoxin is effective after oral administration to
control the heart rate at rest (NOT in exercise).
Diltiazem tab 60 mg
Price of each pack (100 tablets): 13,000 Toman
Diltiazem 120 mg
Price of each pack: 17,000 Toman
Diltiazem 2%
Price of each pack: 6,500 Toman
Verapamil tablet 40 mg
Price of each pack: 7,000 Toman
Verapamil ampule 5 mg / 2 ml
Price of each ampule: 3,500 Toman
Digoxin tablet 0.25 mg
Price of each package (50 tablets) 8,000 Toman
Digoxin ampule 0.25 mg/ml
Price of each package (10 ampule) ??? Toman
Digoxin antibody vial 40 mg/4 ml
Price of each package (1 vial) 12,300,000 Toman!!
Atrial Fibrillation (AF or AFib)
 For antithrombotic therapy aspirin, or warfarin, or
Dabigatran is used.
 The risk factors for thromboembolism are: age ≥75
years, hypertension, heart failure, EF ≤35%, and
diabetes.
 If none of these risk factors is present, aspirin is used .
 If only one risk factor is present, either aspirin or an
anticoagulant is used, and the choice is individualized.
 If more than one risk factor is present, anticoagulant is
used.
Atrial Fibrillation (AF or AFib)
 For post MI AF: cardioversion for patients with
severe hemodynamic instability.
 For AF in pregnancy: Digoxin, a beta blocker, or a
nondihydropyridine CCB, or cardioversion (if the
patient is unstable).
 Antithrombotic therapy is indicated throughout
pregnancy and depends on the stage of pregnancy.
Warfarin tab
Available forms in Iran
Dabigatran capsule 75 mg
Dabigatran capsule 110 mg
Dabigatran capsule 150 mg
Rivaroxaban tablet 10 mg
Price of each package (30 tablets) 98,400 Toman
Rivaroxaban tablet 15 mg
Price of each package (30 tablets) 105,000 Toman
Rivaroxaban tablet 20 mg
price of each package (30 tablets) 120,000 Toman
AV Nodal Reentrant Tachycardia (AVNRT)
 For some patients, rest may be all that is required to
abort the attack.
 These vagal maneuvers serve as the first line of
therapy:
 Carotid sinus massage
 Valsalva maneuvers
 Müller maneuvers
 Gagging
 Occasionally exposure of the face to ice water
AV Nodal Reentrant Tachycardia (AVNRT)
 If vagal maneuvers fail, adenosine is the drug of choice
and terminates (within 1 minute) the tachycardia in 90%
of cases.
 If adenosine fails, verapamil, or diltiazem terminates
reentry in about 2 minutes in 90% of cases.
Adenosine 6 mg /2 ml
Price of each pack: 23,000 Toman
Adenosine 6 mg /2 ml
Price of each Vial: 23,000 Toman
Preexcitation Syndrome (WPW)
 Asymptomatic patients with intermittent complexes are
only observed.
 Two therapeutic options exist, catheter ablation and
pharmacologic therapy.
 For acute episodes, treatment is similar to AVNRT.
 After vagal maneuvers, adenosine followed by IV
verapamil or diltiazem is the treatment of choice.
 AF can occur after adenosine, so a cardioverter-
defibrillator should be immediately available if necessary.
AV Block
 For short-term therapy, vagolytic agents such as
atropine are useful for patients who have AV nodal
disturbances.
 Isoproterenol can be used to treat heart block at any
site.
 Isoproterenol should NOT be used in patients with
acute MI.
 For symptomatic AV block or high-grade AV block,
pacemaker placement is the treatment of choice.
Atropine ampule 0.5 mg/ml
Price of each package (10
ampules) 13,700 Toman
PVC
 In most patients, PVCs do not need to be treated.
 Reassurance that they are benign in those without
structural heart disease is often sufficient.
 In hospitalized patients, IV lidocaine is the treatment
of choice but is rarely indicated.
 Intravenous magnesium may be useful.
Lidocaine
Lidocaine 2%
Price of each unit : 1,800 Toman
Magnesium Sulfate 20% & 50% / 50 ml
Price of each Vial : 5,300 Toman
Magnesium Sulfate 50%
Price of each ampule : 3,000 Toman
Ventricular Tachycardia (VT)
 VT that does not cause hemodynamic
decompensation is treated by IV amiodarone, or
procainamide.
 If the arrhythmia does not respond to medical
therapy, cardioversion (10 – 50 J) is used.
 When a defibrillator is not available, striking the
patient’s chest can infrequently terminate the VT.
Ventricular Flutter and Fibrillation
 Immediate nonsynchronized DC electrical shock
using 200 to 400 J is mandatory therapy for:
 ventricular Fibrillation (VF)
 ventricular flutter
 pulseless VT.
Thank you
Any question?
Osborn wave in Hypothermia
A 76-year-old woman with a history of dementia and coronary
heart disease was brought to the emergency department after
she had been found lying outdoors for an undetermined
period; her core body temperature was 26°C (78.8°F) at
presentation.
An electrocardiogram showed prominent Osborn waves, also
known as J waves (Panel A, arrows), along with prolonged
QRS duration and corrected QT interval.
Hypothermia induces an increase in the activity of the cardiac
transient outward potassium current, which is more prominent
in the epicardium than in the endocardium. This
heterogeneous distribution of potassium current results in J
waves that are typically observed in the inferior and lateral
precordial leads, as seen in this patient.
After the patient was rewarmed for 12 hours, the J waves
disappeared, and the QT interval and QRS duration
normalized
Osborn wave in Hypothermia
Frog sign
“Frog Sign” in Atrioventricular
Nodal Reentrant Tachycardia
Frog sign
“Frog Sign” in Atrioventricular
Nodal Reentrant Tachycardia
Frog sign
“Frog Sign” in Atrioventricular
Nodal Reentrant Tachycardia
An 83-year-old man with frequent palpitations.
Examination of the neck revealed rapid and regular pulsations
with bulging of the internal jugular veins.
ECG showed a regular, narrow-complex tachycardia, with
narrow P waves deforming the terminal QRS complex.
On the application of pressure to the carotid sinus, sinus rhythm
was restored.
The arrhythmia is an AV nodal reentrant tachycardia.
In its typical form, anterograde conduction occurs over the slow
pathway to the ventricle, while near-simultaneous atrial
activation occurs over the fast pathway of the AV node.
These events lead to the parallel contraction of the atria and
ventricles against closed atrioventricular valves, causing a reflux
of blood into the neck veins (frog sign).
Frog sign

More Related Content

What's hot

ACE ACE inhibitors and ARBs in Heart Failure -What Does the evidence say?
ACE  ACE inhibitors and  ARBs in  Heart Failure -What Does the evidence say?ACE  ACE inhibitors and  ARBs in  Heart Failure -What Does the evidence say?
ACE ACE inhibitors and ARBs in Heart Failure -What Does the evidence say?
Syed Raza
 
Role of ACE Inhibitors as Secondary Prevention in ACS
Role of ACE Inhibitors as Secondary Prevention in ACSRole of ACE Inhibitors as Secondary Prevention in ACS
Role of ACE Inhibitors as Secondary Prevention in ACS
PERKI Pekanbaru
 
Mana Of Susp Mi Fina Lfinal
Mana Of Susp Mi Fina LfinalMana Of Susp Mi Fina Lfinal
Mana Of Susp Mi Fina Lfinal
hospital
 
Atrial fibrillation...rx
Atrial fibrillation...rxAtrial fibrillation...rx
Atrial fibrillation...rx
Praveen Nagula
 
Take home message
Take home messageTake home message
Take home message
drucsamal
 
2016 acc focused update on new pharmacological therapy for heart failure
2016 acc focused update on new pharmacological therapy for heart failure2016 acc focused update on new pharmacological therapy for heart failure
2016 acc focused update on new pharmacological therapy for heart failure
PRAVEEN GUPTA
 
Rivaroxaban
RivaroxabanRivaroxaban
Rivaroxabantgraphos
 
Ontarget
OntargetOntarget
3 dan atar - rate versus rhythm control in af
3   dan atar - rate versus rhythm control in af3   dan atar - rate versus rhythm control in af
3 dan atar - rate versus rhythm control in af
webevo5
 
Newer drugs aliskerin and ivabradine
Newer drugs aliskerin and ivabradineNewer drugs aliskerin and ivabradine
Newer drugs aliskerin and ivabradine
Siddhesh Kalantri
 
Clinical trial ivabradine
Clinical trial ivabradineClinical trial ivabradine
Clinical trial ivabradine
Amogh Kawle
 
Estudio PARADIGM-HF: LCZ696 en Insuficiencia Cardiaca
Estudio PARADIGM-HF: LCZ696 en Insuficiencia CardiacaEstudio PARADIGM-HF: LCZ696 en Insuficiencia Cardiaca
Estudio PARADIGM-HF: LCZ696 en Insuficiencia Cardiaca
CardioTeca
 
New day in heart failure
New day in heart failureNew day in heart failure
New day in heart failure
Waseem Omar
 
PARADIGM HF Journal Club
PARADIGM HF Journal ClubPARADIGM HF Journal Club
PARADIGM HF Journal ClubAmy Yeh
 
Angiotensin Receptor Neprilysin + Valsartan
Angiotensin Receptor Neprilysin + ValsartanAngiotensin Receptor Neprilysin + Valsartan
Angiotensin Receptor Neprilysin + Valsartan
Jai Parekh
 
Angiotensin receptor-neprilysin inhibition(ARNI):The New Fronteir ?
Angiotensin receptor-neprilysin inhibition(ARNI):The New Fronteir ?Angiotensin receptor-neprilysin inhibition(ARNI):The New Fronteir ?
Angiotensin receptor-neprilysin inhibition(ARNI):The New Fronteir ?
drucsamal
 
Péptidos natriuréticos, nuestra protección endógena frente a la IC
Péptidos natriuréticos, nuestra protección endógena frente a la ICPéptidos natriuréticos, nuestra protección endógena frente a la IC
Péptidos natriuréticos, nuestra protección endógena frente a la IC
Sociedad Española de Cardiología
 
Paradigm hf-trial-ppt-pptx - copia
Paradigm hf-trial-ppt-pptx - copiaParadigm hf-trial-ppt-pptx - copia
Paradigm hf-trial-ppt-pptx - copia
Edgardo Kaplinsky
 

What's hot (20)

ACE ACE inhibitors and ARBs in Heart Failure -What Does the evidence say?
ACE  ACE inhibitors and  ARBs in  Heart Failure -What Does the evidence say?ACE  ACE inhibitors and  ARBs in  Heart Failure -What Does the evidence say?
ACE ACE inhibitors and ARBs in Heart Failure -What Does the evidence say?
 
Role of ACE Inhibitors as Secondary Prevention in ACS
Role of ACE Inhibitors as Secondary Prevention in ACSRole of ACE Inhibitors as Secondary Prevention in ACS
Role of ACE Inhibitors as Secondary Prevention in ACS
 
Mana Of Susp Mi Fina Lfinal
Mana Of Susp Mi Fina LfinalMana Of Susp Mi Fina Lfinal
Mana Of Susp Mi Fina Lfinal
 
Atrial fibrillation...rx
Atrial fibrillation...rxAtrial fibrillation...rx
Atrial fibrillation...rx
 
Take home message
Take home messageTake home message
Take home message
 
2016 acc focused update on new pharmacological therapy for heart failure
2016 acc focused update on new pharmacological therapy for heart failure2016 acc focused update on new pharmacological therapy for heart failure
2016 acc focused update on new pharmacological therapy for heart failure
 
Rivaroxaban
RivaroxabanRivaroxaban
Rivaroxaban
 
Ontarget
OntargetOntarget
Ontarget
 
3 dan atar - rate versus rhythm control in af
3   dan atar - rate versus rhythm control in af3   dan atar - rate versus rhythm control in af
3 dan atar - rate versus rhythm control in af
 
Newer drugs aliskerin and ivabradine
Newer drugs aliskerin and ivabradineNewer drugs aliskerin and ivabradine
Newer drugs aliskerin and ivabradine
 
Clinical trial ivabradine
Clinical trial ivabradineClinical trial ivabradine
Clinical trial ivabradine
 
Estudio PARADIGM-HF: LCZ696 en Insuficiencia Cardiaca
Estudio PARADIGM-HF: LCZ696 en Insuficiencia CardiacaEstudio PARADIGM-HF: LCZ696 en Insuficiencia Cardiaca
Estudio PARADIGM-HF: LCZ696 en Insuficiencia Cardiaca
 
New day in heart failure
New day in heart failureNew day in heart failure
New day in heart failure
 
Dr. Sharma 2
Dr. Sharma 2Dr. Sharma 2
Dr. Sharma 2
 
Arni
ArniArni
Arni
 
PARADIGM HF Journal Club
PARADIGM HF Journal ClubPARADIGM HF Journal Club
PARADIGM HF Journal Club
 
Angiotensin Receptor Neprilysin + Valsartan
Angiotensin Receptor Neprilysin + ValsartanAngiotensin Receptor Neprilysin + Valsartan
Angiotensin Receptor Neprilysin + Valsartan
 
Angiotensin receptor-neprilysin inhibition(ARNI):The New Fronteir ?
Angiotensin receptor-neprilysin inhibition(ARNI):The New Fronteir ?Angiotensin receptor-neprilysin inhibition(ARNI):The New Fronteir ?
Angiotensin receptor-neprilysin inhibition(ARNI):The New Fronteir ?
 
Péptidos natriuréticos, nuestra protección endógena frente a la IC
Péptidos natriuréticos, nuestra protección endógena frente a la ICPéptidos natriuréticos, nuestra protección endógena frente a la IC
Péptidos natriuréticos, nuestra protección endógena frente a la IC
 
Paradigm hf-trial-ppt-pptx - copia
Paradigm hf-trial-ppt-pptx - copiaParadigm hf-trial-ppt-pptx - copia
Paradigm hf-trial-ppt-pptx - copia
 

Similar to treatment of cardiac arrhythmias 2

Samir rafla ecg arrhythmia for medical students- 70 slides
Samir rafla  ecg arrhythmia for medical students- 70 slidesSamir rafla  ecg arrhythmia for medical students- 70 slides
Samir rafla ecg arrhythmia for medical students- 70 slides
Alexandria University, Egypt
 
Arrhythmia management
Arrhythmia managementArrhythmia management
Arrhythmia management
AndrewCrofton
 
Atrial Fibrillation 2016
Atrial Fibrillation 2016Atrial Fibrillation 2016
Atrial Fibrillation 2016
Dr. Lazaro Nicanor Rodriguez Gonzalez
 
Supra ventricular tachycardia
Supra ventricular tachycardiaSupra ventricular tachycardia
Supra ventricular tachycardiaTamil Mani
 
Samir rafla ecg arrhythmia for medical students- added amr kamal
Samir rafla  ecg arrhythmia for medical students- added amr kamalSamir rafla  ecg arrhythmia for medical students- added amr kamal
Samir rafla ecg arrhythmia for medical students- added amr kamal
SamirRafla1
 
Approach to a case of narrow complex tachycardia
Approach to a case of narrow complex tachycardiaApproach to a case of narrow complex tachycardia
Approach to a case of narrow complex tachycardia
Praveen Nagula
 
Atrial Fibrillation - BMH/Tele
Atrial Fibrillation - BMH/TeleAtrial Fibrillation - BMH/Tele
Atrial Fibrillation - BMH/TeleTeleClinEd
 
ECG emergencies
ECG emergenciesECG emergencies
ECG emergencies
Hasnein Mohamedali MD
 
ATRIAL FIBULLATION.pptx
ATRIAL  FIBULLATION.pptxATRIAL  FIBULLATION.pptx
ATRIAL FIBULLATION.pptx
AsmauBelko
 
Atrial fibrillation ksaus hs 2019
Atrial fibrillation ksaus hs 2019Atrial fibrillation ksaus hs 2019
Atrial fibrillation ksaus hs 2019
hospital
 
Supra ventricular tachyarrhythmia
Supra ventricular tachyarrhythmia    Supra ventricular tachyarrhythmia
Supra ventricular tachyarrhythmia
200020002000
 
Cardiac rhythm disorders
Cardiac rhythm disordersCardiac rhythm disorders
Cardiac rhythm disorders
Lih Yin Chong
 
Atrial Fibrillation By Dr Joshua Walinjom.ppt
Atrial Fibrillation By Dr Joshua Walinjom.pptAtrial Fibrillation By Dr Joshua Walinjom.ppt
Atrial Fibrillation By Dr Joshua Walinjom.ppt
Dr. Joshua WALINJOM
 
0 - how to approach my patient with ventricular arrhythmia-samir rafla
0 - how to approach my patient with ventricular arrhythmia-samir rafla0 - how to approach my patient with ventricular arrhythmia-samir rafla
0 - how to approach my patient with ventricular arrhythmia-samir rafla
Alexandria University, Egypt
 
Atrial fibrillation
Atrial fibrillationAtrial fibrillation
Atrial fibrillation
tarun kumar
 
Approach to tachyarrhythmia
Approach to tachyarrhythmiaApproach to tachyarrhythmia
Approach to tachyarrhythmia
KTD Priyadarshani
 
2015 svt guideline final 19.10.2015
2015 svt guideline final 19.10.20152015 svt guideline final 19.10.2015
2015 svt guideline final 19.10.2015
dibufolio
 
Abcd emergency drugs
Abcd emergency drugsAbcd emergency drugs
Abcd emergency drugsOrdeen McLean
 

Similar to treatment of cardiac arrhythmias 2 (20)

Samir Rafla - ECG arrhythmia for medical students
Samir Rafla - ECG arrhythmia for medical studentsSamir Rafla - ECG arrhythmia for medical students
Samir Rafla - ECG arrhythmia for medical students
 
Peri-arrest Arrhythmias
Peri-arrest ArrhythmiasPeri-arrest Arrhythmias
Peri-arrest Arrhythmias
 
Samir rafla ecg arrhythmia for medical students- 70 slides
Samir rafla  ecg arrhythmia for medical students- 70 slidesSamir rafla  ecg arrhythmia for medical students- 70 slides
Samir rafla ecg arrhythmia for medical students- 70 slides
 
Arrhythmia management
Arrhythmia managementArrhythmia management
Arrhythmia management
 
Atrial Fibrillation 2016
Atrial Fibrillation 2016Atrial Fibrillation 2016
Atrial Fibrillation 2016
 
Supra ventricular tachycardia
Supra ventricular tachycardiaSupra ventricular tachycardia
Supra ventricular tachycardia
 
Samir rafla ecg arrhythmia for medical students- added amr kamal
Samir rafla  ecg arrhythmia for medical students- added amr kamalSamir rafla  ecg arrhythmia for medical students- added amr kamal
Samir rafla ecg arrhythmia for medical students- added amr kamal
 
Approach to a case of narrow complex tachycardia
Approach to a case of narrow complex tachycardiaApproach to a case of narrow complex tachycardia
Approach to a case of narrow complex tachycardia
 
Atrial Fibrillation - BMH/Tele
Atrial Fibrillation - BMH/TeleAtrial Fibrillation - BMH/Tele
Atrial Fibrillation - BMH/Tele
 
ECG emergencies
ECG emergenciesECG emergencies
ECG emergencies
 
ATRIAL FIBULLATION.pptx
ATRIAL  FIBULLATION.pptxATRIAL  FIBULLATION.pptx
ATRIAL FIBULLATION.pptx
 
Atrial fibrillation ksaus hs 2019
Atrial fibrillation ksaus hs 2019Atrial fibrillation ksaus hs 2019
Atrial fibrillation ksaus hs 2019
 
Supra ventricular tachyarrhythmia
Supra ventricular tachyarrhythmia    Supra ventricular tachyarrhythmia
Supra ventricular tachyarrhythmia
 
Cardiac rhythm disorders
Cardiac rhythm disordersCardiac rhythm disorders
Cardiac rhythm disorders
 
Atrial Fibrillation By Dr Joshua Walinjom.ppt
Atrial Fibrillation By Dr Joshua Walinjom.pptAtrial Fibrillation By Dr Joshua Walinjom.ppt
Atrial Fibrillation By Dr Joshua Walinjom.ppt
 
0 - how to approach my patient with ventricular arrhythmia-samir rafla
0 - how to approach my patient with ventricular arrhythmia-samir rafla0 - how to approach my patient with ventricular arrhythmia-samir rafla
0 - how to approach my patient with ventricular arrhythmia-samir rafla
 
Atrial fibrillation
Atrial fibrillationAtrial fibrillation
Atrial fibrillation
 
Approach to tachyarrhythmia
Approach to tachyarrhythmiaApproach to tachyarrhythmia
Approach to tachyarrhythmia
 
2015 svt guideline final 19.10.2015
2015 svt guideline final 19.10.20152015 svt guideline final 19.10.2015
2015 svt guideline final 19.10.2015
 
Abcd emergency drugs
Abcd emergency drugsAbcd emergency drugs
Abcd emergency drugs
 

More from Mohammad Hadi Farjoo MD, PhD, Shahid behehsti University of Medical Sciences

Applied statistics part 5
Applied statistics part 5Applied statistics part 5
Applied statistics part 4
Applied statistics part  4Applied statistics part  4
Applied statistics part 3
Applied statistics part 3Applied statistics part 3
Applied statistics part 2
Applied statistics  part 2Applied statistics  part 2
Applied statistics part 1
Applied statistics part 1Applied statistics part 1
Drugs used in disorders of coagulation
Drugs used in disorders of coagulationDrugs used in disorders of coagulation
Agents used in anemias hematopoietic growth factors
Agents used in anemias hematopoietic growth factorsAgents used in anemias hematopoietic growth factors
Agents used in anemias hematopoietic growth factors
Mohammad Hadi Farjoo MD, PhD, Shahid behehsti University of Medical Sciences
 
Drugs used in dyslipidemia
Drugs used in dyslipidemiaDrugs used in dyslipidemia
Immunopharmacology
Immunopharmacology Immunopharmacology
Management of the poisoned patient.
Management of the poisoned patient.Management of the poisoned patient.
Rational prescribing & prescription writing
Rational prescribing & prescription writingRational prescribing & prescription writing
Drug use in pregnancy and lactation part 2
Drug use in pregnancy and lactation part 2Drug use in pregnancy and lactation part 2
Drug use in pregnancy and lactation part 1
Drug use in pregnancy and lactation part 1Drug use in pregnancy and lactation part 1
Drug use in pregnancy and lactation part 3
Drug use in pregnancy and lactation part 3Drug use in pregnancy and lactation part 3
Drugs causing methemoglobinemia
Drugs causing methemoglobinemiaDrugs causing methemoglobinemia
Drugs pharmacology in kidney disease
Drugs pharmacology in kidney diseaseDrugs pharmacology in kidney disease
Drugs pharmacology in liver disease
Drugs pharmacology in liver diseaseDrugs pharmacology in liver disease
Drugs pharmacology in lung disease
Drugs pharmacology in lung diseaseDrugs pharmacology in lung disease
Drugs pharmacology in heart disease
Drugs pharmacology in heart diseaseDrugs pharmacology in heart disease
Academic writing 2nd part 6 bahman 1398
Academic writing 2nd part 6 bahman 1398Academic writing 2nd part 6 bahman 1398

More from Mohammad Hadi Farjoo MD, PhD, Shahid behehsti University of Medical Sciences (20)

Applied statistics part 5
Applied statistics part 5Applied statistics part 5
Applied statistics part 5
 
Applied statistics part 4
Applied statistics part  4Applied statistics part  4
Applied statistics part 4
 
Applied statistics part 3
Applied statistics part 3Applied statistics part 3
Applied statistics part 3
 
Applied statistics part 2
Applied statistics  part 2Applied statistics  part 2
Applied statistics part 2
 
Applied statistics part 1
Applied statistics part 1Applied statistics part 1
Applied statistics part 1
 
Drugs used in disorders of coagulation
Drugs used in disorders of coagulationDrugs used in disorders of coagulation
Drugs used in disorders of coagulation
 
Agents used in anemias hematopoietic growth factors
Agents used in anemias hematopoietic growth factorsAgents used in anemias hematopoietic growth factors
Agents used in anemias hematopoietic growth factors
 
Drugs used in dyslipidemia
Drugs used in dyslipidemiaDrugs used in dyslipidemia
Drugs used in dyslipidemia
 
Immunopharmacology
Immunopharmacology Immunopharmacology
Immunopharmacology
 
Management of the poisoned patient.
Management of the poisoned patient.Management of the poisoned patient.
Management of the poisoned patient.
 
Rational prescribing & prescription writing
Rational prescribing & prescription writingRational prescribing & prescription writing
Rational prescribing & prescription writing
 
Drug use in pregnancy and lactation part 2
Drug use in pregnancy and lactation part 2Drug use in pregnancy and lactation part 2
Drug use in pregnancy and lactation part 2
 
Drug use in pregnancy and lactation part 1
Drug use in pregnancy and lactation part 1Drug use in pregnancy and lactation part 1
Drug use in pregnancy and lactation part 1
 
Drug use in pregnancy and lactation part 3
Drug use in pregnancy and lactation part 3Drug use in pregnancy and lactation part 3
Drug use in pregnancy and lactation part 3
 
Drugs causing methemoglobinemia
Drugs causing methemoglobinemiaDrugs causing methemoglobinemia
Drugs causing methemoglobinemia
 
Drugs pharmacology in kidney disease
Drugs pharmacology in kidney diseaseDrugs pharmacology in kidney disease
Drugs pharmacology in kidney disease
 
Drugs pharmacology in liver disease
Drugs pharmacology in liver diseaseDrugs pharmacology in liver disease
Drugs pharmacology in liver disease
 
Drugs pharmacology in lung disease
Drugs pharmacology in lung diseaseDrugs pharmacology in lung disease
Drugs pharmacology in lung disease
 
Drugs pharmacology in heart disease
Drugs pharmacology in heart diseaseDrugs pharmacology in heart disease
Drugs pharmacology in heart disease
 
Academic writing 2nd part 6 bahman 1398
Academic writing 2nd part 6 bahman 1398Academic writing 2nd part 6 bahman 1398
Academic writing 2nd part 6 bahman 1398
 

Recently uploaded

Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 

Recently uploaded (20)

Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 

treatment of cardiac arrhythmias 2

  • 1.
  • 2. Treatment of cardiac Arrhythmias For Reform Students By M. H. Farjoo M.D , Ph.D Shahid Beheshti University of Medical Sciences
  • 3. Treatment of Cardiac Arrhythmias  Drug Classes  Supraventricular Arrhythmias  Atrial Flutter  Atrial Fibrillation  AV Nodal Reentrant Tachycardia  Preexcitation Syndrome (WPW)  AV Block  PVC  Ventricular Tachycardia  Ventricular Flutter & Fibrillation & arrest
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10. Supraventricular Arrhythmias  Atrial fibrillation and atrial flutter are common supraventricular tachycardias.  Premature atrial complexes (PAC), sinus arrhythmia, sinus tachycardia, and sinus bradycardia usually do NOT require drug therapy.  In symptomatic patients with PAC, treatment with a beta blocker or a CCB can be attempted.
  • 11.
  • 12. Atrial Flutter  Cardioversion (synchronous, 50 J) is the treatment of choice.  Catheter ablation is preferred for stable patients who do not require immediate cardioversion.  Procainamide or amiodarone can be given.
  • 13.
  • 14. Amiodarone 150 mg / 3 ml Price of each ampule: 3,500 Toman
  • 15.
  • 16.
  • 17. Atrial Fibrillation (AF or AFib)  AF is the most prevalent arrhythmia and 33% of arrhythmia-related hospitalizations are for AF.  AF treatment is based upon:  Rate control or rhythm control  Prevention of Thromboembolism  Pharmacologic rhythm-control and rate-control strategies result in similar outcomes.
  • 18. Atrial Fibrillation (AF or AFib)  In the absence of preexcitation, a beta blocker or nondihydropyridine CCB is used for AF.  IV digoxin or amiodarone is used in AF with heart failure and without accessory pathway.  Digoxin is effective after oral administration to control the heart rate at rest (NOT in exercise).
  • 19. Diltiazem tab 60 mg Price of each pack (100 tablets): 13,000 Toman
  • 20. Diltiazem 120 mg Price of each pack: 17,000 Toman
  • 21. Diltiazem 2% Price of each pack: 6,500 Toman
  • 22. Verapamil tablet 40 mg Price of each pack: 7,000 Toman
  • 23. Verapamil ampule 5 mg / 2 ml Price of each ampule: 3,500 Toman
  • 24. Digoxin tablet 0.25 mg Price of each package (50 tablets) 8,000 Toman
  • 25. Digoxin ampule 0.25 mg/ml Price of each package (10 ampule) ??? Toman
  • 26. Digoxin antibody vial 40 mg/4 ml Price of each package (1 vial) 12,300,000 Toman!!
  • 27. Atrial Fibrillation (AF or AFib)  For antithrombotic therapy aspirin, or warfarin, or Dabigatran is used.  The risk factors for thromboembolism are: age ≥75 years, hypertension, heart failure, EF ≤35%, and diabetes.  If none of these risk factors is present, aspirin is used .  If only one risk factor is present, either aspirin or an anticoagulant is used, and the choice is individualized.  If more than one risk factor is present, anticoagulant is used.
  • 28. Atrial Fibrillation (AF or AFib)  For post MI AF: cardioversion for patients with severe hemodynamic instability.  For AF in pregnancy: Digoxin, a beta blocker, or a nondihydropyridine CCB, or cardioversion (if the patient is unstable).  Antithrombotic therapy is indicated throughout pregnancy and depends on the stage of pregnancy.
  • 33. Rivaroxaban tablet 10 mg Price of each package (30 tablets) 98,400 Toman
  • 34. Rivaroxaban tablet 15 mg Price of each package (30 tablets) 105,000 Toman
  • 35. Rivaroxaban tablet 20 mg price of each package (30 tablets) 120,000 Toman
  • 36. AV Nodal Reentrant Tachycardia (AVNRT)  For some patients, rest may be all that is required to abort the attack.  These vagal maneuvers serve as the first line of therapy:  Carotid sinus massage  Valsalva maneuvers  Müller maneuvers  Gagging  Occasionally exposure of the face to ice water
  • 37. AV Nodal Reentrant Tachycardia (AVNRT)  If vagal maneuvers fail, adenosine is the drug of choice and terminates (within 1 minute) the tachycardia in 90% of cases.  If adenosine fails, verapamil, or diltiazem terminates reentry in about 2 minutes in 90% of cases.
  • 38. Adenosine 6 mg /2 ml Price of each pack: 23,000 Toman
  • 39. Adenosine 6 mg /2 ml Price of each Vial: 23,000 Toman
  • 40.
  • 41. Preexcitation Syndrome (WPW)  Asymptomatic patients with intermittent complexes are only observed.  Two therapeutic options exist, catheter ablation and pharmacologic therapy.  For acute episodes, treatment is similar to AVNRT.  After vagal maneuvers, adenosine followed by IV verapamil or diltiazem is the treatment of choice.  AF can occur after adenosine, so a cardioverter- defibrillator should be immediately available if necessary.
  • 42.
  • 43.
  • 44.
  • 45. AV Block  For short-term therapy, vagolytic agents such as atropine are useful for patients who have AV nodal disturbances.  Isoproterenol can be used to treat heart block at any site.  Isoproterenol should NOT be used in patients with acute MI.  For symptomatic AV block or high-grade AV block, pacemaker placement is the treatment of choice.
  • 46. Atropine ampule 0.5 mg/ml Price of each package (10 ampules) 13,700 Toman
  • 47.
  • 48.
  • 49. PVC  In most patients, PVCs do not need to be treated.  Reassurance that they are benign in those without structural heart disease is often sufficient.  In hospitalized patients, IV lidocaine is the treatment of choice but is rarely indicated.  Intravenous magnesium may be useful.
  • 51. Lidocaine 2% Price of each unit : 1,800 Toman
  • 52. Magnesium Sulfate 20% & 50% / 50 ml Price of each Vial : 5,300 Toman
  • 53. Magnesium Sulfate 50% Price of each ampule : 3,000 Toman
  • 54.
  • 55. Ventricular Tachycardia (VT)  VT that does not cause hemodynamic decompensation is treated by IV amiodarone, or procainamide.  If the arrhythmia does not respond to medical therapy, cardioversion (10 – 50 J) is used.  When a defibrillator is not available, striking the patient’s chest can infrequently terminate the VT.
  • 56.
  • 57.
  • 58.
  • 59. Ventricular Flutter and Fibrillation  Immediate nonsynchronized DC electrical shock using 200 to 400 J is mandatory therapy for:  ventricular Fibrillation (VF)  ventricular flutter  pulseless VT.
  • 60.
  • 62. Osborn wave in Hypothermia
  • 63. A 76-year-old woman with a history of dementia and coronary heart disease was brought to the emergency department after she had been found lying outdoors for an undetermined period; her core body temperature was 26°C (78.8°F) at presentation. An electrocardiogram showed prominent Osborn waves, also known as J waves (Panel A, arrows), along with prolonged QRS duration and corrected QT interval. Hypothermia induces an increase in the activity of the cardiac transient outward potassium current, which is more prominent in the epicardium than in the endocardium. This heterogeneous distribution of potassium current results in J waves that are typically observed in the inferior and lateral precordial leads, as seen in this patient. After the patient was rewarmed for 12 hours, the J waves disappeared, and the QT interval and QRS duration normalized Osborn wave in Hypothermia
  • 64. Frog sign “Frog Sign” in Atrioventricular Nodal Reentrant Tachycardia
  • 65. Frog sign “Frog Sign” in Atrioventricular Nodal Reentrant Tachycardia
  • 66. Frog sign “Frog Sign” in Atrioventricular Nodal Reentrant Tachycardia
  • 67. An 83-year-old man with frequent palpitations. Examination of the neck revealed rapid and regular pulsations with bulging of the internal jugular veins. ECG showed a regular, narrow-complex tachycardia, with narrow P waves deforming the terminal QRS complex. On the application of pressure to the carotid sinus, sinus rhythm was restored. The arrhythmia is an AV nodal reentrant tachycardia. In its typical form, anterograde conduction occurs over the slow pathway to the ventricle, while near-simultaneous atrial activation occurs over the fast pathway of the AV node. These events lead to the parallel contraction of the atria and ventricles against closed atrioventricular valves, causing a reflux of blood into the neck veins (frog sign). Frog sign